Last reviewed · How we verify
AMNIOGEN
AMNIOGEN is an amniotic membrane-derived biological product that promotes tissue repair and regeneration through growth factors and anti-inflammatory signaling.
AMNIOGEN is an amniotic membrane-derived biological product that promotes tissue repair and reduces inflammation. Used for Wound healing and tissue repair, Ocular surface disease, Burn and trauma wound management.
At a glance
| Generic name | AMNIOGEN |
|---|---|
| Sponsor | Kaohsiung Veterans General Hospital. |
| Drug class | Biological tissue product / Regenerative medicine |
| Modality | Small molecule |
| Therapeutic area | Regenerative Medicine / Wound Care |
| Phase | FDA-approved |
Mechanism of action
The product is derived from processed amniotic membrane tissue, which contains naturally occurring growth factors, cytokines, and extracellular matrix components. These bioactive molecules facilitate wound healing, reduce inflammation, and promote cellular regeneration when applied topically or injected. The mechanism leverages the inherent regenerative properties of amniotic tissue to support tissue repair in various clinical applications.
Approved indications
- Wound healing and tissue repair
- Burn treatment
- Chronic wounds
Common side effects
- Infection at application site
- Allergic reaction
- Local inflammation
Key clinical trials
- Amniotic Suspension Allograft Injection for Knee Osteoarthritis (PHASE3)
- Efficacy of Intra-articular Injection of Human Amniotic Suspension Allograft and Platelet-rich Plasma in the Treatment of Knee Osteoarthritis. (NA)
- Prospective Analysis of Intraoperative AMNIOGEN® Injection in Patients With Rotator Cuff Tear (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |